Shopping Cart
Your shopping cart is empty
Login
Register
Forgot Password?
Home
Products
Suppliers
News
Promotions
Helpdesk
Vacature
About Bio-Connect
Our Divisions
Our Team
Quality and Environmental Management
Meet us at
Contact
COVID-19 Reagents
Antibodies
Arrays / Slides
Assays
Body Products
(Cell) Culture
Chemicals
DNA / RNA / Vectors
Expression
Genome Editing and Engineering
Labware / Accessories
Lysates / Extracts
Molecular Biology
Proteins / Signaling Molecules
Technique Specific Products
Targets
Join us
Medewerker Customer Service
Description
Catalog number
CAS No.
Clone ID
Order information
Order online, fax your order to +31 (0)26 326 4451 or e-mail your order to
orders(at)bio-connect.nl
.
Need another amount?
Contact us
to find out the possibilities.
Can't find what you are looking for?
Bio-Connect Services specialises in assisting you in finding all the products you need for your research. Check out our video to see how it works or go to
www.bio-connectservices.com/how-it-works
.
News
CleanNGS designed for both DNA and RNA purification
VectorBuilder
RevMAb Biosciences new in our portfolio
New high-throughput exosome isolation
FUJIFILM Wako Shibayagi ELISA kits
CD antibodies
New highly specific SARS-CoV-2 Neutralizing Antibodies Detection Kit
Ferroptosis/Oxytosis antibody panel
Viral antigen bank
Highly pure neuron cultures
Vorige
Volgende
Imatinib, Methanesulfonate Salt [220127-57-1]
Catalog number:
ORB61045_2g
Brand:
Biorbyt
Packing:
2 g
Other sizes:
500 mg
1 g
10 g
5 g
25 g
Price:
€ 390.00
Expected delivery time:
14 days
Quantity:
Spin Up
Spin Down
General
Product specifications for - Imatinib, Methanesulfonate Salt [220127-57-1]
Overview:
Product group:
Chemicals
Category:
Inhibitors / activators
CAS No.:
220127-57-1
Properties:
Datasheet:
Datasheet
Research Use Only
UNSPSC:
12352200
Form supplied:
H2O (200 mM), DMSO (200 mM), Ethanol (<1 mM)
Scientific information:
Scientific info:
Imatinib Mesylate is orally bioavailability mesylate salt of Imatinib, which is a multi-target inhibitor of v-Abl, c-Kit and PDGFR with IC50 of 0.6 muM, 0.1 muM and 0.1 muM, respectively. Imatinib is currently being investigated in Phase III clinical tri
Additional information:
Synonyms:
ORB61045